The judging panel comprises leaders in innovation, healthcare and business, including representatives from Astellas and our partners.
Mark Reisenauer has been Senior Vice President of the Oncology Business Unit at Astellas Pharma US, Inc., since May 2011. A veteran oncology commercial leader, Mark is responsible for all US commercial activities supporting marketed products and Astellas Pharma's oncology co-promotion partners. He also leads commercial planning for early-stage development compounds.
“Many of us have been touched by cancer. Our experiences are powerful and emotional motivators. I encourage applicants to turn your idea and your connection to cancer into motivation. If you have an idea, bring it forward.”
Mark was a caregiver for his father, who battled head and neck cancer before passing away on his 80th birthday.
Bill Rancic is a businessman and TV personality who rose to fame after winning the first season of The Apprentice. He is a published author and motivational speaker covering the subject of entrepreneurship and business. Bill's New York Times best-selling book, You're Hired: How to Succeed in Business and Life, chronicles Bill's successful life, experience and proven advice.
“Supporting small businesses – and that’s really what these are, are small businesses – doing important, great work… that’s what we should be doing.”
Bill acted as a caregiver for his wife, Giuliana, who was diagnosed with cancer in 2011, and is excited to join the C3 Prize program for his second year and help inspire fellow entrepreneurs to pursue their ideas.
Hernâni, a biomedical researcher and PhD candidate in digital media, currently leads the development of the first Portuguese Health Literacy Laboratory at the University of Porto. Their mission is to increase health literacy and quality of life through the dissemination of disruptive products. He won the 2017 C3 Prize for his video game–influenced "exergaming" app, The HOPE Project, designed to increase activity levels and reduce anxiety in children with cancer during and between hospital visits.
“I love seeing work on improving communication between patients and healthcare professionals. We need to focus on holistic solutions, on tools that can help inform people.”
Hernâni is a cancer survivor.
Abbie is a partner at Third Rock Ventures with over 30 years of experience in Senior R&D and Executive leadership roles. At Third Rock Ventures, Abbie focuses on the formation, development and strategy of its portfolio companies, with a particular interest in emerging technologies and new advances in science.
“It takes a person with courage and dedication to take an idea and turn it into a reality. The C3 Prize helps empower courageous leaders, so that their ideas can help more people impacted by cancer.”
Abbie is a member of the MassBio board of directors and is dedicated to supporting the organization's diversity and inclusion efforts.
Margaret Laws is a catalytic leader in health care, forging cross-sector partnerships that drive positive social impact. She is the President and CEO of HopeLab, where she leads a team to create science-based technologies to improve the health and well-being of teens and young adults. Margaret also founded the CHCF Health Innovation Fund, a mission-focused investment fund supporting companies that improve access to and lower costs of health care.
“I am a strong believer in the value of forging cross-sector partnerships in order to drive positive social impact, and I know we can help the lives of those impacted by cancer by doing so.”
Margaret is passionate about bringing together government, nonprofit and private-sector stakeholders interested in advancing the role technology can play in supporting and improving health outcomes, with a particular focus on underserved populations.